Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Zealand changes policy on antenatal HIV screening:

This article was originally published in Clinica

Executive Summary

New Zealand is to move towards routine antenatal HIV screening in line with the practice in Australia, the UK and elsewhere. In accordance with recommendations in the National Health Committee's "HIV screening in pregnancy" report 2004, the new policy will be piloted in an area of Auckland (Waikato) before it is implemented nationwide. The change in policy follows criticism that the current approach, of testing only high-risk patients, is being poorly implemented. New Zealand has a low but rising incidence of HIV.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055635

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel